Cover Image
市場調查報告書

e-Therapeutics plc:產品平台分析

e-Therapeutics Plc - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224610
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
e-Therapeutics plc:產品平台分析 e-Therapeutics Plc - Product Pipeline Review - 2015
出版日期: 2015年07月15日 內容資訊: 英文 34 Pages
簡介

e-Therapeutics plc在網路藥理學上使用獨家平台技術來開發新藥。尤其致力於癌症及中樞神經系統疾病等隨著年老之疾病治療藥的候補。

本報告提供e-Therapeutics plc的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

e-Therapeutics plc的基本資料

  • e-Therapeutics plc概要
  • 主要資訊
  • 企業資料

e-Therapeutics plc:R&D概要

  • 主要的治療範圍

e-Therapeutics plc:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

e-Therapeutics plc:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

e-Therapeutics plc:藥物簡介

  • tramadol hydrochloride
  • ETS-2101
  • 腫瘤治療藥
  • 中樞神經系統治療藥
  • ETS-2123
  • ETX-6991

e-Therapeutics plc:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

e-Therapeutics plc:最近的開發平台趨勢

e-Therapeutics plc:暫停中的計劃

e-Therapeutics plc:企業發表

e-Therapeutics plc:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07308CDB

Summary

Global Markets Direct's, 'e-Therapeutics plc - Product Pipeline Review - 2015', provides an overview of the e-Therapeutics plc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of e-Therapeutics plc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of e-Therapeutics plc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of e-Therapeutics plc's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the e-Therapeutics plc's pipeline products

Reasons to buy

  • Evaluate e-Therapeutics plc's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of e-Therapeutics plc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the e-Therapeutics plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of e-Therapeutics plc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of e-Therapeutics plc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of e-Therapeutics plc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • e-Therapeutics Plc Snapshot
    • e-Therapeutics Plc Overview
    • Key Information
    • Key Facts
  • e-Therapeutics Plc - Research and Development Overview
    • Key Therapeutic Areas
  • e-Therapeutics Plc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • e-Therapeutics Plc - Pipeline Products Glance
    • e-Therapeutics Plc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • e-Therapeutics Plc - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • e-Therapeutics Plc - Drug Profiles
    • tramadol hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ETS-2101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs for Central Nervous System Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ETS-2123
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ETX-6991
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • e-Therapeutics Plc - Pipeline Analysis
    • e-Therapeutics Plc - Pipeline Products by Target
    • e-Therapeutics Plc - Pipeline Products by Route of Administration
    • e-Therapeutics Plc - Pipeline Products by Molecule Type
    • e-Therapeutics Plc - Pipeline Products by Mechanism of Action
  • e-Therapeutics Plc - Recent Pipeline Updates
  • e-Therapeutics Plc - Dormant Projects
  • e-Therapeutics Plc - Company Statement
  • e-Therapeutics Plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • e-Therapeutics Plc, Key Information
  • e-Therapeutics Plc, Key Facts
  • e-Therapeutics Plc - Pipeline by Indication, 2015
  • e-Therapeutics Plc - Pipeline by Stage of Development, 2015
  • e-Therapeutics Plc - Monotherapy Products in Pipeline, 2015
  • e-Therapeutics Plc - Phase II, 2015
  • e-Therapeutics Plc - Phase I, 2015
  • e-Therapeutics Plc - Discovery, 2015
  • e-Therapeutics Plc - Pipeline by Target, 2015
  • e-Therapeutics Plc - Pipeline by Route of Administration, 2015
  • e-Therapeutics Plc - Pipeline by Molecule Type, 2015
  • e-Therapeutics Plc - Pipeline Products by Mechanism of Action, 2015
  • e-Therapeutics Plc - Recent Pipeline Updates, 2015
  • e-Therapeutics Plc - Dormant Developmental Projects,2015
  • e-Therapeutics Plc, Other Locations
  • e-Therapeutics Plc, Subsidiaries

List of Figures

  • e-Therapeutics Plc - Pipeline by Top 10 Indication, 2015
  • e-Therapeutics Plc - Pipeline by Stage of Development, 2015
  • e-Therapeutics Plc - Monotherapy Products in Pipeline, 2015
  • e-Therapeutics Plc - Pipeline by Top 10 Target, 2015
  • e-Therapeutics Plc - Pipeline by Top 10 Route of Administration, 2015
  • e-Therapeutics Plc - Pipeline by Top 10 Molecule Type, 2015
  • e-Therapeutics Plc - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top